Are you Dr. Kochenderfer?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 6 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
Nih
Bldg 10
Bethesda, MD 20892Phone+1 240-760-6062
Summary
- Dr. James Kochenderfer, MD is a hematologist in Bethesda, Maryland. He is currently licensed to practice medicine in Tennessee and Texas.
Education & Training
West Virginia University School of MedicineClass of 1995
Certifications & Licensure
TX State Medical License 1998 - 2026
TN State Medical License 1998 - 1999- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- 289 citationsLong-term outcomes following CAR T cell therapy: what we know so far.Kathryn M Cappell, James N Kochenderfer
Nature Reviews. Clinical Oncology. 2023-06-01 - 1174 citationsChemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chime...James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert Somerville, Robert O. Carpenter
Journal of Clinical Oncology. 2015-02-20 - 982 citationsEradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19James N. Kochenderfer, Wyndham H. Wilson, John E. Janik, Mark E. Dudley, Maryalice Stetler-Stevenson
Blood. 2010-11-18
Press Mentions
Novel 'Off the Shelf' CAR-T Product Shows Promise in MyelomaFebruary 2nd, 2023- CRISPR Gene-Editing May Boost Cancer Immunotherapy, New Study FindsDecember 13th, 2022
- Insurance “Roadblock” Delays Initiation of “Potentially Lifesaving” CAR-T Therapy in LymphomaDecember 20th, 2023
- Join now to see all
